Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer
Background: Concurrent chemoradiation with 3 weekly cisplatin (100 mg/m2) is the standard of care for locally advanced head and neck cancer. However, this regimen has been shown to be associated with lesser compliance and higher toxicities. Hence, there is a need to explore alternative concurrent ci...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017-01-01
|
| シリーズ: | South Asian Journal of Cancer |
| 主題: | |
| オンライン･アクセス: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=2;spage=64;epage=68;aulast=Nair |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|